As discussed in a previous
article, the
Anti-Kickback Statute is violated when remuneration is exchanged with the
intent to induce or reward referrals. Both parties can be criminally liable and
convicted of a felony punishable by a maximum fine of $25,000, imprisonment up
to five years, or both. Laboratories that pay referring physicians for services
may be suspect under the Anti-Kickback Statute because the payment could be for
inducing the physician’s Federal health care program referrals.
There are two specific arrangements the OIG
identified as involving transfers of value from laboratories to physicians that
can present a substantial risk of fraud and abuse under the Anti-Kickback
Statute.
1.
Arrangements under which the laboratories are providing
remuneration to physicians to collect, process, and package patients’ blood
specimens. These arrangements are
referred to as Specimen Processing Arrangements.
2.
The government has also become aware of arrangements under
which laboratories are collecting data on the demographics or other attributes
of patients who have undergone certain tests performed by the offering
laboratories. These arrangements are referred to as Registry Payment
Arrangements.
The OIG is increasing
enforcement regarding payment arrangements between laboratories and physicians,
especially with respect to these two arrangements. If you or your organization are involved in
similar arrangements and have questions regarding the Anti-Kickback
Statute risk, or have any other compliance
concerns, please contact Alex T. Krouse at (574) 485-2003 or Susan E. Ziel at (612) 564-1927.